TY - JOUR
T1 - Racial Disparities in Charges, Length of Stay, and Complications Following Adult Inpatient Epistaxis Treatment
AU - Randhawa, Avneet
AU - Randhawa, Karandeep S.
AU - Tseng, Christopher C.
AU - Fang, Christina H.
AU - Baredes, Soly
AU - Eloy, Jean Anderson
N1 - Publisher Copyright:
© The Author(s) 2022.
PY - 2023/1
Y1 - 2023/1
N2 - Background: Although recent studies have identified an association between race and adverse outcomes in head and neck surgeries, there are limited data examining the impact of racial disparities on adult inpatient outcomes following epistaxis management procedures. Objective: To analyze the association between race and adverse outcomes in hospitalized patients undergoing epistaxis treatment. Methods: This retrospective cohort analysis utilized the 2003 to 2014 National Inpatient Sample. International Classification of Diseases, Ninth Revision codes were used to identify cases with a primary diagnosis of epistaxis that underwent a procedure for epistaxis control. Cases with missing data were excluded. Higher total charges and prolonged length of stay (LOS) were indicated by values greater than the 75th percentile. Demographics, hospital characteristics, Elixhauser comorbidity score, and complications were compared among race cohorts using univariate chi-square analysis and one-way analysis of variance (ANOVA). The independent effect of race on adverse outcomes was analyzed using multivariate binary logistic regression while adjusting for the aforementioned variables. Results: Of the 83 356 cases of epistaxis included, 80.3% were White, 12.5% Black, and 7.2% Hispanic. Black patients had increased odds of urinary/renal complications (odds ratio [OR] 2.148, 95% confidence interval [CI] 1.797-2.569, P <.001) compared to White patients. Additionally, Black patients experienced higher odds of prolonged LOS (OR 1.227, 95% CI 1.101-1.367, P <.001) and higher total charges (OR 1.257, 95% CI 1.109-1.426, P <.001) compared to White patients. Similarly, Hispanic patients were more likely to experience urinary/renal complications (OR 1.605, 95% CI 1.244-2.071, P <.001), higher total charges (OR 1.519, 95% CI 1.302-1.772, P <.001), and prolonged LOS (OR 1.157, 95% CI 1.007-1.331, P =.040) compared to White patients. Conclusion: Race is an important factor associated with an increased incidence of complications in hospitalized patients treated for epistaxis.
AB - Background: Although recent studies have identified an association between race and adverse outcomes in head and neck surgeries, there are limited data examining the impact of racial disparities on adult inpatient outcomes following epistaxis management procedures. Objective: To analyze the association between race and adverse outcomes in hospitalized patients undergoing epistaxis treatment. Methods: This retrospective cohort analysis utilized the 2003 to 2014 National Inpatient Sample. International Classification of Diseases, Ninth Revision codes were used to identify cases with a primary diagnosis of epistaxis that underwent a procedure for epistaxis control. Cases with missing data were excluded. Higher total charges and prolonged length of stay (LOS) were indicated by values greater than the 75th percentile. Demographics, hospital characteristics, Elixhauser comorbidity score, and complications were compared among race cohorts using univariate chi-square analysis and one-way analysis of variance (ANOVA). The independent effect of race on adverse outcomes was analyzed using multivariate binary logistic regression while adjusting for the aforementioned variables. Results: Of the 83 356 cases of epistaxis included, 80.3% were White, 12.5% Black, and 7.2% Hispanic. Black patients had increased odds of urinary/renal complications (odds ratio [OR] 2.148, 95% confidence interval [CI] 1.797-2.569, P <.001) compared to White patients. Additionally, Black patients experienced higher odds of prolonged LOS (OR 1.227, 95% CI 1.101-1.367, P <.001) and higher total charges (OR 1.257, 95% CI 1.109-1.426, P <.001) compared to White patients. Similarly, Hispanic patients were more likely to experience urinary/renal complications (OR 1.605, 95% CI 1.244-2.071, P <.001), higher total charges (OR 1.519, 95% CI 1.302-1.772, P <.001), and prolonged LOS (OR 1.157, 95% CI 1.007-1.331, P =.040) compared to White patients. Conclusion: Race is an important factor associated with an increased incidence of complications in hospitalized patients treated for epistaxis.
KW - National Inpatient Sample
KW - disparity
KW - epistaxis
KW - head and neck
KW - outcomes
KW - race
UR - http://www.scopus.com/inward/record.url?scp=85139653018&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85139653018&partnerID=8YFLogxK
U2 - 10.1177/19458924221130880
DO - 10.1177/19458924221130880
M3 - Article
C2 - 36221850
AN - SCOPUS:85139653018
SN - 1945-8924
VL - 37
SP - 51
EP - 57
JO - American Journal of Rhinology and Allergy
JF - American Journal of Rhinology and Allergy
IS - 1
ER -